Skip to main content

Table 2 Comparison of the included colon cancer patient´s HRQoL with the Swedish reference population (Standard) at baseline and 6-month follow-up, univariate analyses. Data for men and women presented separately

From: Risk factors for poor health-related quality of life in patients with colon cancer include stoma and smoking habits

Men Standarda Baseline Follow-up
Scale n Mean (SD) n Mean (SD) Pstandardb n Mean (SD) Pstandardc nd Pdiffe
Global health status 230 76.4 (22.8) 177 59.7 (23.6) < 0.001 132 68.0 (22.4) 0.001 130 0.008
Functional scales           
Physical functioning 224 81.6 (22.7) 178 79.0 (20.8) 0.232 130 80.5 (18.5) 0.629 129 0.083
Role functioning 224 82.6 (29.7) 178 67.2 (34.7) < 0.001 130 72.7 (31.4) 0.004 129 0.577
Emotional functioning 223 88.2 (17.3) 178 74.7 (21.1) < 0.001 132 81.1 (22.3) 0.002 131 0.006
Cognitive functioning 228 85.2 (16.9) 178 85.3 (17.3) 0.954 132 83.1 (20.4) 0.313 131 0.074
Social function 230 89.1 (21.1) 178 77.9 (25.0) < 0.001 132 73.3 (28.9) < 0.001 131 0.020
Symptom scales/items           
Fatigue 227 21.5 (23.1) 178 39.0 (25.7) < 0.001 132 33.7 (24.0) < 0.001 131 0.350
Nausea and vomiting 234 2.5 (10.0) 178 9.5 (18.4) < 0.001 132 5.6 (12.5) 0.017 131 0.527
Pain 226 19.2 (25.0) 178 23.0 (26.9) 0.144 132 14.8 (22.2) 0.084 131 0.013
Dyspnoea 232 23.7 (29.4) 178 29.2 (29.8) 0.062 130 27.4 (26.4) 0.216 129 0.525
Insomnia 231 11.8 (22.5) 178 26.7 (29.7) < 0.001 132 21.0 (29.8) 0.002 131 0.017
Appetite loss 233 2.7 (11.9) 178 21.2 (32.2) < 0.001 132 10.9 (23.8) < 0.001 131 0.036
Constipation 234 6.7 (17.7) 178 12.8 (25.6) 0.007 131 6.4 (16.6) 0.855 129 0.049
Diarrhoea 231 4.2 (13.1) 177 24.1 (31.2) < 0.001 131 18.6 (24.9) < 0.001 130 0.422
Financial difficulties 230 5.4 (16.0) 175 6.5 (18.5) 0.539 132 8.8 (23.6) 0.138 129 0.015
Women Standarda Baseline Vås Follow-up
Scale n Mean (SD) n Mean (SD) Pstandb n Mean (SD) Pstandc nd Pdiffe
Global health status 285 69.9 (25.0) 192 59.2 (22.9) < 0.001 157 66.5 (23.7) 0.152 153 0.001
Functional scales           
Physical functioning 283 74.2 (23.6) 190 72.0 (21.0) 0.296 157 73.6 (20.9) 0.779 151 0.477
Role functioning 280 80.4 (29.6) 191 67.9 (32.6) < 0.001 156 72.8 (29.7) 0.010 151 0.497
Emotional functioning 277 80.4 (22.0) 192 69.0 (22.6) < 0.001 156 76.9 (23.6) 0.133 153 < 0.001
Cognitive functioning 282 85.6 (19.5) 192 81.3 (22.2) 0.032 157 81.6 (23.9) 0.077 153 0.686
Social functioning 272 89.9 (21.3) 191 76.8 (24.5) < 0.001 157 75.4 (28.4) < 0.001 152 0.406
Symptom scales/items           
Fatigue 285 28.2 (25.0) 192 39.7 (25.3) < 0.001 157 36.0 (26.4) 0.003 153 0.265
Nausea and vomiting 298 3.7 (12.4) 192 9.5 (18.4) < 0.001 157 6.8 (26.4) 0.038 153 0.033
Pain 280 26.7 (30.5) 192 24.9 (28.7) 0.518 157 22.5 (29.0) 0.155 153 0.448
Dyspnoea 295 22.3 (27.5) 189 22.9 (26.5) 0.802 156 20.1 (26.1) 0.401 149 0.456
Insomnia 295 26.4 (31.2) 191 30.1 (31.6) 0.216 156 34.6 (32.1) 0.009 151 0.258
Appetite loss 299 7.4 (18.5) 191 27.2 (32.5) < 0.001 155 16.8 (27.5) < 0.001 151 < 0.001
Constipation 298 8.6 (19.6) 190 16.7 (29.6) 0.001 155 11.2 (23.2) 0.238 150 0.014
Diarrhoea 287 5.0 (14.8) 187 24.4 (31.0) < 0.001 155 20.0 (27.3) < 0.001 147 0.046
Financial difficulties 284 8.1 (21.2) 192 8.0 (21.1) 0.954 155 9.7 (25.5) 0.512 151 0.160
  1. aValues in the standard population were from sex-specific data for ages 70–79 years given by Michelson et al. (2000)
  2. bP values for difference between values at baseline and values in the standard population, Significant P values are given in bold
  3. cP values for difference between values at follow-up and values in the standard population
  4. dNumber of individuals with answers at both baseline and follow-up
  5. eP values for difference between values at baseline and follow-up